Physician profile
Garrett Michael Gilbert
NPI 1295398014
$4,901.24
in general payments reported to CMS, 2019-2025
9 companies · $767 in 2025
The $767 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $457 · 2020: $77.71 · 2021: $483 · 2022: $2,781 · 2023: $59.04 · 2024: $277 · 2025: $767.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,103.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,338.61 | 2020-2025 | Mako, Alphavent, Procinch |
| Titan Surgical Group, LLC | $1,346.58 | 2022-2025 | |
| Medical Device Business Services, INC. | $777.94 | 2019-2021 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $147.30 | 2025 | Rexulti |
| Depuy Synthes Sales INC. | $131.46 | 2019-2025 | Va-Lcp, Lcp, Na |
| Acumed LLC | $77.46 | 2025 | Acumed |
| Smith+Nephew, INC. | $49.15 | 2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Linvatec Corporation | $20.51 | 2025 | Biobrace 23mm, Anchor |
| Paragon 28, INC. | $12.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garrett Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.